GOSS Gossamer Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GOSS

Price (delayed)

$10.99

Market cap

$67.16M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$45.6

Enterprise value

$65.11M

?
Relative Growth: Rel. Growth: 35
Relative Strength: Rel. Strength: 3
Relative Valuation: Rel. Valuation: 29
Relative Profitability: Rel. Profitability: 30
Highlights
The debt has dropped by 81% since the previous quarter and by 81% year-on-year
Gossamer Bio's net income has increased by 31% from the previous quarter and by 10% YoY
GOSS's equity has shrunk by 104% YoY but it is up by 42% QoQ
GOSS's gross profit is up by 32% year-on-year but it is down by 4.1% since the previous quarter
The quick ratio has dropped by 89% year-on-year and by 76% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.gossamerbio.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of GOSS

GOSS stock price

How has the Gossamer Bio stock price performed over time
Intraday
-5.99%
1 week
0.27%
1 month
-11.23%
1 year
-95.54%
YTD
-95.57%
QTD
-16.55%

Financial performance

How have Gossamer Bio's revenue and profit performed over time
Revenue
$53.29M
Gross profit
$53.29M
Operating income
-$166.09M
Net income
-$125.22M
Gross margin
100%
Net margin
-235%
GOSS's gross profit is up by 32% year-on-year but it is down by 4.1% since the previous quarter
The net margin rose by 32% year-on-year and by 28% since the previous quarter
GOSS's revenue is up by 32% YoY but it is down by 4.1% QoQ
Gossamer Bio's net income has increased by 31% from the previous quarter and by 10% YoY

Price vs fundamentals

How does GOSS's price correlate with its fundamentals

Growth

What is Gossamer Bio's growth rate over time

Valuation

What is Gossamer Bio stock price valuation
P/E
N/A
P/B
N/A
P/S
0.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.22
GOSS's EPS is up by 28% since the previous quarter and by 8% year-on-year
GOSS's equity has shrunk by 104% YoY but it is up by 42% QoQ
GOSS's price to sales (P/S) is 89% lower than its last 4 quarters average of 7.7
GOSS's revenue is up by 32% YoY but it is down by 4.1% QoQ

Efficiency

How efficient is Gossamer Bio business performance
Gossamer Bio's ROIC has plunged by 85% YoY and by 4.1% from the previous quarter
GOSS's ROA has dropped by 83% year-on-year but it is up by 11% since the previous quarter
GOSS's ROS is up by 34% year-on-year and by 30% since the previous quarter

Dividends

What is GOSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GOSS.

Financial health

How did Gossamer Bio financials performed over time
GOSS's total assets is 55% lower than its total liabilities
The quick ratio has dropped by 89% year-on-year and by 76% since the previous quarter
The current ratio has plunged by 88% YoY and by 76% from the previous quarter
The debt is 142% greater than the equity
GOSS's equity has shrunk by 104% YoY but it is up by 42% QoQ
The company's debt to equity has surged by 90% YoY and by 66% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.